Opinion

Video

Need for Sustained Anti-VEGF Delivery System for Neovascular AMD

Video content above is prompted by the following:

  • Why is sustained delivery of anti-VEGF necessary, and what challenges arise from frequent anti-VEGF injections?
  • Can you provide an overview of the port delivery system with ranibizumab?
    • How does the device function?
    • How is the device implanted?
    • How is the device refilled?
  • What gives you confidence in using the PDS system despite its recall in 2022 after the initial launch?
Related Videos
Caroline Piatek, MD: Improving Patient-Reported Outcomes in PNH With Danicopan Add-on Therapy
Haydar Frangoul, MD: Preventing VOCs in People With Sickle Cell Disease With Exa-Cel Gene Editing Therapy
Andreas Kremer, MD, PhD, MHBA | Credit: AASLD
Andreas Kremer, MD, PhD, MHBA | Credit: AASLD
Andreas Kremer, MD, PhD, MHBA | Credit: AASLD
Andreas Kremer, MD, PhD, MHBA | Credit: AASLD
Jörn Schattenberg, MD | Credit: Novo Nordisk
Diabetes Dialogue: Diabetes Tech Updates from November 2024 | Image Credit: HCPLive
© 2024 MJH Life Sciences

All rights reserved.